The International Conference and
Exhibition on Biowaivers & Biosimilars
(Biosimilars-2012), is offering a formal
forum for the exchange of ideas
concerning the development and progress
of research in the areas of drug
discovery, clinical trials, regulatory
and economic considerations towards
Biosimilars and Waiver for
Bioequivalence Studies, BCS Biowaiver
Studies, Dosage forms, Dissolution
Testing and IVIVC.
The conference is known for bringing
together national and international
scientists from academia, the
pharmaceutical industry, the
biotechnology industry and regulatory
agencies for the opportunity to learn of
and discuss new initiatives for finding
a better way to develop new drugs and
improve the quality of existing drug
products.
We also have a B2B session for all
professionals who want to have
collaborations.
Important Dates:
Abstracts submission will closed 45 days
ahead of the conference.
Early bird registration will closes 90
days ahead of the conference.
